Bhalani Biomedicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 43.20 Cr
as on 15-11-2024
- Satisfied Charges ₹ 10.55 Cr
as on 15-11-2024
- Revenue -59.27%
(FY 2023)
- Profit -1.75%
(FY 2023)
- Ebitda -127.06%
(FY 2023)
- Net Worth 76.86%
(FY 2023)
- Total Assets -17.35%
(FY 2023)
About Bhalani Biomedicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹43.20 Cr. The company has closed loans amounting to ₹10.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hiren Bhalani and Jigna Hiren serve as directors at the Company.
- CIN/LLPIN
U33100MH2005PTC153754
- Company No.
153754
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jun 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Bhalani Biomedicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hiren Bhalani  | Director | 03-Jun-2005 | Current |
| Jigna Hiren | Director | 03-Jun-2005 | Current |
Financial Performance and Corporate Structure Insights of Bhalani Biomedicals.
Bhalani Biomedicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 59.27% decrease. The company also saw a slight decrease in profitability, with a 1.75% decrease in profit. The company's net worth Soared by an impressive increase of 76.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhalani Biomedicals?
In 2023, Bhalani Biomedicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ajitnath Healthcare Private LimitedActive 3 years 19 daysHiren Bhalani and Jigna Hiren are mutual person
- Ajitnath Associates Private LimitedActive 3 years 4 months
Hiren Bhalani and Jigna Hiren are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Aug 2020 | ₹2.40 M | Open |
Standard Chartered Bank Creation Date: 11 Feb 2020 | ₹22.18 Cr | Open |
Others Creation Date: 18 Oct 2012 | ₹3.00 Cr | Open |
How Many Employees Work at Bhalani Biomedicals?
Unlock and access historical data on people associated with Bhalani Biomedicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhalani Biomedicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhalani Biomedicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
